Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.

Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	American Society for Microbiology 2017

Eitemau Tebyg

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
gan: Chotsiri, P, et al.
Cyhoeddwyd: (2019)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
gan: Palang Chotsiri, et al.
Cyhoeddwyd: (2019-01-01)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
gan: Bergstrand, M, et al.
Cyhoeddwyd: (2014)

Efficacy and safety of dihydroartemisinin-piperaquine.
gan: Myint, H, et al.
Cyhoeddwyd: (2007)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
gan: Lwin, K, et al.
Cyhoeddwyd: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
gan: Lwin, K, et al.
Cyhoeddwyd: (2012)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
gan: Zongo, I, et al.
Cyhoeddwyd: (2015)

The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
gan: Achan, J, et al.
Cyhoeddwyd: (2013)

Quantification of the antimalarial piperaquine in plasma.
gan: Tarning, J, et al.
Cyhoeddwyd: (2008)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
gan: Tarning, J, et al.
Cyhoeddwyd: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
gan: Tarning, J, et al.
Cyhoeddwyd: (2008)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
gan: Tarning, J, et al.
Cyhoeddwyd: (2008)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
gan: Tarning, J, et al.
Cyhoeddwyd: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
gan: Zongo, I, et al.
Cyhoeddwyd: (2014)

The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data.
gan: WorldWide Antimalarial Resistance Network (WWARN) DP Study Group
Cyhoeddwyd: (2013-12-01)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
gan: Rijken, M, et al.
Cyhoeddwyd: (2011)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
gan: Issaka Zongo, et al.
Cyhoeddwyd: (2014-01-01)

Characterization of human urinary metabolites of the antimalarial piperaquine.
gan: Tarning, J, et al.
Cyhoeddwyd: (2006)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
gan: Tarning, J, et al.
Cyhoeddwyd: (2007)

Correction: The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data.
Cyhoeddwyd: (2013-12-01)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
gan: Chotsiri, P, et al.
Cyhoeddwyd: (2017)

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania
gan: Richard Mwaiswelo, et al.
Cyhoeddwyd: (2024-01-01)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
gan: Phuc, B, et al.
Cyhoeddwyd: (2017)

Repurposing Dihydroartemisinin-Piperaquine-Doxycycline as an Antimalarial Drug: A Study in Plasmodium berghei-Infected Mice
gan: Udeme Owunari Georgewill, et al.
Cyhoeddwyd: (2021-12-01)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
gan: Tarning, J, et al.
Cyhoeddwyd: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
gan: Tarning, J, et al.
Cyhoeddwyd: (2014)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
gan: Byakika-Kibwika, P, et al.
Cyhoeddwyd: (2019)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
gan: Mytton, O, et al.
Cyhoeddwyd: (2007)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
gan: Bui Quang Phuc, et al.
Cyhoeddwyd: (2017-04-01)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
gan: Lwin, K, et al.
Cyhoeddwyd: (2010)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
gan: Pauline Byakika-Kibwika, et al.
Cyhoeddwyd: (2019-12-01)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
gan: Ashley, E, et al.
Cyhoeddwyd: (2004)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
gan: Hanboonkunupakarn, B, et al.
Cyhoeddwyd: (2014)

Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children
gan: Erika Wallender, et al.
Cyhoeddwyd: (2021-11-01)

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial
gan: Kamya, MR, et al.
Cyhoeddwyd: (2007)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
gan: Thanh, N, et al.
Cyhoeddwyd: (2017)

Detection of Falsified Antimalarial Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine Drugs Using a Low-Cost Handheld Near-Infrared Spectrometer
gan: Moussa Yabré, et al.
Cyhoeddwyd: (2022-01-01)

Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment
gan: Leang, R, et al.
Cyhoeddwyd: (2015)

Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand
gan: Khine Nwe Win, et al.
Cyhoeddwyd: (2022-11-01)